Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 117

1.

Distinct encoding of decision confidence in human medial prefrontal cortex.

Bang D, Fleming SM.

Proc Natl Acad Sci U S A. 2018 Jun 5;115(23):6082-6087. doi: 10.1073/pnas.1800795115. Epub 2018 May 21.

PMID:
29784814
2.

Neural mediators of changes of mind about perceptual decisions.

Fleming SM, van der Putten EJ, Daw ND.

Nat Neurosci. 2018 Apr;21(4):617-624. doi: 10.1038/s41593-018-0104-6. Epub 2018 Mar 12.

PMID:
29531361
3.

Domain-General and Domain-Specific Patterns of Activity Supporting Metacognition in Human Prefrontal Cortex.

Morales J, Lau H, Fleming SM.

J Neurosci. 2018 Apr 4;38(14):3534-3546. doi: 10.1523/JNEUROSCI.2360-17.2018. Epub 2018 Mar 8.

4.

Assessing cognitive dysfunction in Parkinson's disease: An online tool to detect visuo-perceptual deficits.

Weil RS, Schwarzkopf DS, Bahrami B, Fleming SM, Jackson BM, Goch TJC, Saygin AP, Miller LE, Pappa K, Pavisic I, Schade RN, Noyce AJ, Crutch SJ, O'Keeffe AG, Schrag AE, Morris HR.

Mov Disord. 2018 Apr;33(4):544-553. doi: 10.1002/mds.27311. Epub 2018 Feb 23.

5.

Psychiatric Symptom Dimensions Are Associated With Dissociable Shifts in Metacognition but Not Task Performance.

Rouault M, Seow T, Gillan CM, Fleming SM.

Biol Psychiatry. 2018 Jan 11. pii: S0006-3223(18)30029-5. doi: 10.1016/j.biopsych.2017.12.017. [Epub ahead of print]

6.

Ahr and Cyp1a2 genotypes both affect susceptibility to motor deficits following gestational and lactational exposure to polychlorinated biphenyls.

Colter BT, Garber HF, Fleming SM, Fowler JP, Harding GD, Hooven MK, Howes AA, Infante SK, Lang AL, MacDougall MC, Stegman M, Taylor KR, Curran CP.

Neurotoxicology. 2018 Mar;65:125-134. doi: 10.1016/j.neuro.2018.01.008.

PMID:
29409959
7.

Exacerbation of sensorimotor dysfunction in mice deficient in Atp13a2 and overexpressing human wildtype alpha-synuclein.

Dirr ER, Ekhator OR, Blackwood R, Holden JG, Masliah E, Schultheis PJ, Fleming SM.

Behav Brain Res. 2018 May 2;343:41-49. doi: 10.1016/j.bbr.2018.01.029. Epub 2018 Feb 3.

PMID:
29407413
8.

Changing Body Movement Patterns in 9-Year-Old Baseball Pitchers: A Pilot Study.

Fehringer EV, Dilisio MF, Greco CE, Fleming SM, Brezenski JW, High RR.

Orthop J Sports Med. 2017 Jun 28;5(6):2325967117713023. doi: 10.1177/2325967117713023. eCollection 2017 Jun.

9.

The effect of manganese exposure in Atp13a2-deficient mice.

Fleming SM, Santiago NA, Mullin EJ, Pamphile S, Karkare S, Lemkuhl A, Ekhator OR, Linn SC, Holden JG, Aga DS, Roth JA, Liou B, Sun Y, Shull GE, Schultheis PJ.

Neurotoxicology. 2018 Jan;64:256-266. doi: 10.1016/j.neuro.2017.06.005. Epub 2017 Jun 6.

PMID:
28595912
10.

HMeta-d: hierarchical Bayesian estimation of metacognitive efficiency from confidence ratings.

Fleming SM.

Neurosci Conscious. 2017 Apr 22;2017(1):nix007. doi: 10.1093/nc/nix007. eCollection 2017.

11.

Mechanisms of Gene-Environment Interactions in Parkinson's Disease.

Fleming SM.

Curr Environ Health Rep. 2017 Jun;4(2):192-199. doi: 10.1007/s40572-017-0143-2. Review.

PMID:
28417442
12.

Suboptimal Criterion Learning in Static and Dynamic Environments.

Norton EH, Fleming SM, Daw ND, Landy MS.

PLoS Comput Biol. 2017 Jan 3;13(1):e1005304. doi: 10.1371/journal.pcbi.1005304. eCollection 2017 Jan.

13.

Self-evaluation of decision-making: A general Bayesian framework for metacognitive computation.

Fleming SM, Daw ND.

Psychol Rev. 2017 Jan;124(1):91-114. doi: 10.1037/rev0000045.

14.

Allostatic Self-efficacy: A Metacognitive Theory of Dyshomeostasis-Induced Fatigue and Depression.

Stephan KE, Manjaly ZM, Mathys CD, Weber LA, Paliwal S, Gard T, Tittgemeyer M, Fleming SM, Haker H, Seth AK, Petzschner FH.

Front Hum Neurosci. 2016 Nov 15;10:550. eCollection 2016.

15.

Changing our minds about changes of mind.

Fleming SM.

Elife. 2016 Mar 7;5:e14790. doi: 10.7554/eLife.14790.

16.

Metacognitive impairment in active cocaine use disorder is associated with individual differences in brain structure.

Moeller SJ, Fleming SM, Gan G, Zilverstand A, Malaker P, d'Oleire Uquillas F, Schneider KE, Preston-Campbell RN, Parvaz MA, Maloney T, Alia-Klein N, Goldstein RZ.

Eur Neuropsychopharmacol. 2016 Apr;26(4):653-62. doi: 10.1016/j.euroneuro.2016.02.009. Epub 2016 Feb 10.

17.

Unexpected but Incidental Positive Outcomes Predict Real-World Gambling.

Otto AR, Fleming SM, Glimcher PW.

Psychol Sci. 2016 Mar;27(3):299-311. doi: 10.1177/0956797615618366. Epub 2016 Jan 21.

PMID:
26796614
18.

Evidence for early and progressive ultrasonic vocalization and oromotor deficits in a PINK1 gene knockout rat model of Parkinson's disease.

Grant LM, Kelm-Nelson CA, Hilby BL, Blue KV, Paul Rajamanickam ES, Pultorak JD, Fleming SM, Ciucci MR.

J Neurosci Res. 2015 Nov;93(11):1713-27. doi: 10.1002/jnr.23625. Epub 2015 Jul 31.

19.

Relating Pupil Dilation and Metacognitive Confidence during Auditory Decision-Making.

Lempert KM, Chen YL, Fleming SM.

PLoS One. 2015 May 7;10(5):e0126588. doi: 10.1371/journal.pone.0126588. eCollection 2015.

20.

Intranasal NAP (davunetide) decreases tau hyperphosphorylation and moderately improves behavioral deficits in mice overexpressing α-synuclein.

Magen I, Ostritsky R, Richter F, Zhu C, Fleming SM, Lemesre V, Stewart AJ, Morimoto BH, Gozes I, Chesselet MF.

Pharmacol Res Perspect. 2014 Oct;2(5):e00065. doi: 10.1002/prp2.65. Epub 2014 Aug 6.

21.

Action-specific disruption of perceptual confidence.

Fleming SM, Maniscalco B, Ko Y, Amendi N, Ro T, Lau H.

Psychol Sci. 2015 Jan;26(1):89-98. doi: 10.1177/0956797614557697. Epub 2014 Nov 25. Erratum in: Psychol Sci. 2015 Apr;26(4):551.

22.

Consciousness science: real progress and lingering misconceptions.

Block N, Carmel D, Fleming SM, Kentridge RW, Koch C, Lamme VA, Lau H, Rosenthal D.

Trends Cogn Sci. 2014 Nov;18(11):556-7. doi: 10.1016/j.tics.2014.09.004. Epub 2014 Oct 4. No abstract available.

PMID:
25287833
23.
24.

Dopamine, Salience, and Response Set Shifting in Prefrontal Cortex.

Shiner T, Symmonds M, Guitart-Masip M, Fleming SM, Friston KJ, Dolan RJ.

Cereb Cortex. 2015 Oct;25(10):3629-39. doi: 10.1093/cercor/bhu210. Epub 2014 Sep 21.

25.

Olfactory assays for mouse models of neurodegenerative disease.

Lehmkuhl AM, Dirr ER, Fleming SM.

J Vis Exp. 2014 Aug 25;(90):e51804. doi: 10.3791/51804.

26.

Domain-specific impairment in metacognitive accuracy following anterior prefrontal lesions.

Fleming SM, Ryu J, Golfinos JG, Blackmon KE.

Brain. 2014 Oct;137(Pt 10):2811-22. doi: 10.1093/brain/awu221. Epub 2014 Aug 6.

27.

How to measure metacognition.

Fleming SM, Lau HC.

Front Hum Neurosci. 2014 Jul 15;8:443. doi: 10.3389/fnhum.2014.00443. eCollection 2014. Review.

28.

Effects of age on metacognitive efficiency.

Palmer EC, David AS, Fleming SM.

Conscious Cogn. 2014 Aug;28:151-60. doi: 10.1016/j.concog.2014.06.007. Epub 2014 Jul 26.

29.

A GCase chaperone improves motor function in a mouse model of synucleinopathy.

Richter F, Fleming SM, Watson M, Lemesre V, Pellegrino L, Ranes B, Zhu C, Mortazavi F, Mulligan CK, Sioshansi PC, Hean S, De La Rosa K, Khanna R, Flanagan J, Lockhart DJ, Wustman BA, Clark SW, Chesselet MF.

Neurotherapeutics. 2014 Oct;11(4):840-56. doi: 10.1007/s13311-014-0294-x.

30.

Ribosomal s15: A novel therapeutic target for Parkinson's disease.

Fleming SM, Espay AJ.

Mov Disord. 2014 Jul;29(8):990. doi: 10.1002/mds.25932. Epub 2014 May 27. No abstract available.

PMID:
24865568
31.

Chronic administration of cholesterol oximes in mice increases transcription of cytoprotective genes and improves transcriptome alterations induced by alpha-synuclein overexpression in nigrostriatal dopaminergic neurons.

Richter F, Gao F, Medvedeva V, Lee P, Bove N, Fleming SM, Michaud M, Lemesre V, Patassini S, De La Rosa K, Mulligan CK, Sioshansi PC, Zhu C, Coppola G, Bordet T, Pruss RM, Chesselet MF.

Neurobiol Dis. 2014 Sep;69:263-75. doi: 10.1016/j.nbd.2014.05.012. Epub 2014 May 18.

32.

Neuroprotective potential of pleiotrophin overexpression in the striatonigral pathway compared with overexpression in both the striatonigral and nigrostriatal pathways.

Gombash SE, Manfredsson FP, Mandel RJ, Collier TJ, Fischer DL, Kemp CJ, Kuhn NM, Wohlgenant SL, Fleming SM, Sortwell CE.

Gene Ther. 2014 Jul;21(7):682-93. doi: 10.1038/gt.2014.42. Epub 2014 May 8.

33.

Morphological and behavioral impact of AAV2/5-mediated overexpression of human wildtype alpha-synuclein in the rat nigrostriatal system.

Gombash SE, Manfredsson FP, Kemp CJ, Kuhn NC, Fleming SM, Egan AE, Grant LM, Ciucci MR, MacKeigan JP, Sortwell CE.

PLoS One. 2013 Nov 27;8(11):e81426. doi: 10.1371/journal.pone.0081426. eCollection 2013.

34.

The irrationality of categorical perception.

Fleming SM, Maloney LT, Daw ND.

J Neurosci. 2013 Dec 4;33(49):19060-70. doi: 10.1523/JNEUROSCI.1263-13.2013.

35.

Characterizing aging in the human brainstem using quantitative multimodal MRI analysis.

Lambert C, Chowdhury R, Fitzgerald TH, Fleming SM, Lutti A, Hutton C, Draganski B, Frackowiak R, Ashburner J.

Front Hum Neurosci. 2013 Aug 20;7:462. doi: 10.3389/fnhum.2013.00462. eCollection 2013.

36.

Impaired baroreflex function in mice overexpressing alpha-synuclein.

Fleming SM, Jordan MC, Mulligan CK, Masliah E, Holden JG, Millard RW, Chesselet MF, Roos KP.

Front Neurol. 2013 Jul 23;4:103. doi: 10.3389/fneur.2013.00103. eCollection 2013.

37.

Assessment of sensorimotor function in mouse models of Parkinson's disease.

Fleming SM, Ekhator OR, Ghisays V.

J Vis Exp. 2013 Jun 17;(76). doi: 10.3791/50303.

38.

Atp13a2-deficient mice exhibit neuronal ceroid lipofuscinosis, limited α-synuclein accumulation and age-dependent sensorimotor deficits.

Schultheis PJ, Fleming SM, Clippinger AK, Lewis J, Tsunemi T, Giasson B, Dickson DW, Mazzulli JR, Bardgett ME, Haik KL, Ekhator O, Chava AK, Howard J, Gannon M, Hoffman E, Chen Y, Prasad V, Linn SC, Tamargo RJ, Westbroek W, Sidransky E, Krainc D, Shull GE.

Hum Mol Genet. 2013 May 15;22(10):2067-82. doi: 10.1093/hmg/ddt057. Epub 2013 Feb 7.

39.

The development of metacognitive ability in adolescence.

Weil LG, Fleming SM, Dumontheil I, Kilford EJ, Weil RS, Rees G, Dolan RJ, Blakemore SJ.

Conscious Cogn. 2013 Mar;22(1):264-71. doi: 10.1016/j.concog.2013.01.004. Epub 2013 Jan 30.

40.

Confidence in value-based choice.

De Martino B, Fleming SM, Garrett N, Dolan RJ.

Nat Neurosci. 2013 Jan;16(1):105-10. doi: 10.1038/nn.3279. Epub 2012 Dec 9.

41.

Inferring subjective states through the observation of actions.

Patel D, Fleming SM, Kilner JM.

Proc Biol Sci. 2012 Dec 7;279(1748):4853-60. doi: 10.1098/rspb.2012.1847. Epub 2012 Oct 3.

42.

Is choice-induced preference change long lasting?

Sharot T, Fleming SM, Yu X, Koster R, Dolan RJ.

Psychol Sci. 2012 Oct 1;23(10):1123-1129. doi: 10.1177/0956797612438733. Epub 2012 Aug 28.

43.

Human responses to unfairness with primary rewards and their biological limits.

Wright ND, Hodgson K, Fleming SM, Symmonds M, Guitart-Masip M, Dolan RJ.

Sci Rep. 2012;2:593. doi: 10.1038/srep00593. Epub 2012 Aug 23.

44.

Testosterone induces off-line perceptual learning.

Wright ND, Edwards T, Fleming SM, Dolan RJ.

Psychopharmacology (Berl). 2012 Dec;224(3):451-7. doi: 10.1007/s00213-012-2769-y. Epub 2012 Jun 17.

45.

Prefrontal contributions to metacognition in perceptual decision making.

Fleming SM, Huijgen J, Dolan RJ.

J Neurosci. 2012 May 2;32(18):6117-25. doi: 10.1523/JNEUROSCI.6489-11.2012.

46.

An online neural substrate for sense of agency.

Chambon V, Wenke D, Fleming SM, Prinz W, Haggard P.

Cereb Cortex. 2013 May;23(5):1031-7. doi: 10.1093/cercor/bhs059. Epub 2012 Apr 17.

PMID:
22510529
47.

The neural basis of metacognitive ability.

Fleming SM, Dolan RJ.

Philos Trans R Soc Lond B Biol Sci. 2012 May 19;367(1594):1338-49. doi: 10.1098/rstb.2011.0417. Review.

48.

Metacognition: computation, biology and function.

Fleming SM, Dolan RJ, Frith CD.

Philos Trans R Soc Lond B Biol Sci. 2012 May 19;367(1594):1280-6. doi: 10.1098/rstb.2012.0021.

49.

Cranial and related sensorimotor impairments in rodent models of Parkinson's disease.

Fleming SM, Schallert T, Ciucci MR.

Behav Brain Res. 2012 Jun 1;231(2):317-22. doi: 10.1016/j.bbr.2012.02.034. Epub 2012 Feb 28. Review.

PMID:
22394540
50.

Cognitive deficits in a mouse model of pre-manifest Parkinson's disease.

Magen I, Fleming SM, Zhu C, Garcia EC, Cardiff KM, Dinh D, De La Rosa K, Sanchez M, Torres ER, Masliah E, Jentsch JD, Chesselet MF.

Eur J Neurosci. 2012 Mar;35(6):870-82. doi: 10.1111/j.1460-9568.2012.08012.x. Epub 2012 Feb 22.

Supplemental Content

Loading ...
Support Center